Your search history is turned on.
Date: April 26, 2024 Jurisdictions: Alberta, Ontario
Create participation fee form FORM 13-502F2 CLASS 2 REPORTING ISSUERS PARTICIPATION FEE MANAGEMENT CERTIFICATION I, BROWN, James, an officer of the reporting issuer noted below have examined this Form 13-502F2 (the Form) being submitted hereunder to the Ontario Securities Commission and certify that to my knowledge, having exercised reasonable diligence, the in...
Create participation fee form FORM 13-501F2 CLASS 2 REPORTING ISSUERS PARTICIPATION FEE MANAGEMENT CERTIFICATION I, BROWN, James, an officer of the reporting issuer noted below have examined this Form 13-501F2 (th e Form) being submitted hereunder to the Alberta Securities Commission and certify that to my knowled ge, having exercised reasonable diligence, the in...
Date: April 26, 2024 Jurisdictions: Alberta, British Columbia, Ontario, Quebec
Form 52-109FV1 Certification of Annual Filings Venture Issuer Basic Certificate I, James R. Brown, Chief Financial Officer, of Capha Pharmaceuticals Inc.. certify the following: 1. Review: I have reviewed the AIF, if any, annual financial statements and annual MD&A, including, for greater certainty, all documents and inform...
Form 52-109FV1 Certification of Annual Filings Venture Issuer Basic Certificate I, James R. Brown, Chief Executive Officer, of Capha Pharmaceuticals Inc., certify the following: 1. Review: I have reviewed the AIF, if any, annual financial statements and annual MD&A, including, for greater certainty, all documents and information th...
MILL CITY GOLD CORP Capha Pharmaceuticals Inc. MANAGEMENT DISCUSSION AND ANALYSIS FOR THE YEAR ENDED DECEMBER 31, 2023 2 Capha Pharmaceuticals Inc. MANAGEMENT DISCUSSION AND ANALYSIS FOR THE YEAR ENDED DECEMBER 31, 2023 Background This discussion and analysis of financia...
Microsoft Word - Capha Pharma FS December 31 2023 v2.docx Capha Pharmaceuticals Inc. Financial Statements For the years ended December 31, 2023 and 2022 (Expressed in Canadian Dollars) Independent Auditor's Report To the Shareholde...
Date: November 28, 2023 Jurisdictions: Alberta, British Columbia, Ontario, Quebec
Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate I, James R. Brown, Chief Financial Officer, of Capha Pharmaceuticals Inc., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together the interim filings) of Capha Pharmaceuticals Inc., (the Issuer) for the ...
Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate I, James R. Brown, President and CEO of Capha Pharmaceuticals Inc., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together the interim filings) of Capha Pharmaceuticals Inc., (the Issuer) for the interim ...
MILL CITY GOLD CORP Capha Pharmaceuticals Inc. MANAGEMENT DISCUSSION AND ANALYSIS FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2023 2 Capha Pharmaceuticals Inc. MANAGEMENT DISCUSSION AND ANALYSIS FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2023 Background This discussion and ana...
Mill City Gold Corp Capha Pharmaceuticals Inc. Interim Financial Statements For the 9 months ended September 30, 2023 (Expressed in Canadian Dollars) (Unaudited Prepared by Management) NOTICE OF NO AUDITOR REVIEW OF INTERIM FINANCIAL ...